Life expectancy of 20-year-olds starting treatment for HIV has increased by around a decade to age 78 in the EU and North America due to improvements in treatment.
The study published in The Lancet authored by University of Bristol researchers suggest that life expectancy of a 20-year-old who began treatment from 2008 onwards and had a low viral load after a year of treatment may approach that of the general population. However, life expectancy for people with HIV mostly remains lower than that of the general population. The authors of the study said they were hopeful that the findings could help to reduce stigmatisation and help people with HIV gain employment and obtain medical insurance. They also hoped it would encourage those diagnosed t...
To continue reading this article...
Join COVER for free
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.